Announcements Trials
Browse Landscape

Phase

Phase 2 11Phase 1 5Phase NA 4Phase 3 2Phase 1/2 2Phase EARLY_PHASE1 1Phase 2/3 1

Status

Withdrawn 1Active not recruiting 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2Gynecologic 1

Conditions

Carcinoma, Non-Small-Cell Lung 14Brain Neoplasms 12Lung Neoplasms 8Neoplasm Metastasis 7Pancreatic Neoplasms 6Liver Neoplasms 6Glioblastoma 6Squamous Cell Carcinoma of Head and Neck 5Carcinoma, Hepatocellular 5Prostatic Neoplasms 4Melanoma 4Carcinoma, Renal Cell 4Neoplasms 3Breast Neoplasms 3Triple Negative Breast Neoplasms 2Ovarian Neoplasms 2Neurologic Manifestations 2Glioma 2Colorectal Neoplasms 2Wilms Tumor 1Urinary Bladder Neoplasms 1Unspecified Adult Solid Tumor, Protocol Specific 1Unspecified Adult Solid Tumor 1Stomach Neoplasms 1Spinal Neoplasms 1Spinal Cord Neoplasms 1Small Cell Lung Carcinoma 1Sarcoma, Ewing 1Sarcoma 1Salivary Gland Neoplasms 1

Interventions

Cetuximab 44Oxaliplatin 39Irinotecan 38Fluorouracil 36Capecitabine 36Bevacizumab 36pembrolizumab 35Leucovorin 34Nivolumab 21Gemcitabine 17regorafenib 13Panitumumab 12IFL protocol 12Folfox protocol 12Cyclophosphamide 12Pemetrexed 11Cisplatin 11tislelizumab 9Paclitaxel 9HMPL-013 9Carboplatin 9130-nm albumin-bound paclitaxel 8durvalumab 7Specimen Handling 7Docetaxel 7trametinib 6Trifluridine 6Ipilimumab 6Drug Therapy 6trifluridine tipiracil drug combination 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 1/2 × Colorectal Neoplasms × Radiosurgery × Clear all
NCT06940921 2025-04-27

SBRT-LDRT-Cadonilimab for Advanced Gastric, Colorectal and Ovarian Cancers With Peritoneal Metastases

First Affiliated Hospital of Chongqing Medical University

Phase 1/2 Active not recruiting
26 enrolled
GastrointestinalGynecologic

Ovarian Neoplasms, Stomach Neoplasms, Colorectal Neoplasms

NCT03169777 2025-02-21

QUILT-3.050: NANT Colorectal Cancer (CRC) Vaccine: Combination Immunotherapy in Subjects With Recurrent or Metastatic CRC

ImmunityBio, Inc.

Phase 1/2 Withdrawn
Gastrointestinal

Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡